header
Image from OpenLibrary

Pelvic angiographic findings in patients with arteriogenic erectile dysfunction : A trial of revascularization / Rasha Abdulaziz Mohammad Zainalabidin ; Supervised Ihab Abdellatif Osman , Ayman Nihad Moharram

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Rasha Abdulaziz Mohammad Zainalabidin , 2016Description: 138 P. : charts , facsimiles ; 25cmOther title:
  • نتائج التصوير الوعائى الحوضى فى مرضى الضعف الجنسى الشريانى : محاولة اعادة التوعية [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology Summary: The aim of the study is to detect pelvic arterial abnormalities in patients with arteriogenic erectile dysfunction and to correlate the presence of these abnormalities with findings of other investigatory methods, also to conduct a trial of revascularization for selected patients. In all, 30 men with arteriogenic ED Non responders to PDE5 inhibitors therapy and post injection max penile systolic velocity <25 cm/s in reported penile duplex ultrasonography were included. Of these, 25 men under go coronary and pelvic angiography after proper preparation and complete personal, medical, sexual history, laboratory testing, local, general and coronary examination, penile duplex study, also the International Index of Erectile Function Questionnaire were taken. Internal pudendal artery abnormalities are an evident finding in almost all patients with arteriogenig ED. Accordingly, PTA of the internal pudendal artery using drug-eluting stent in patients ateriogenic ED, particularly those non responders to PDE5i therapy, seems to be a safe and feasible option to improve arterial inflow, and can result in regaining erectile function.Further randomized controlled studies are needed to assess the efficacy of this new therapeutic modality as compared to the existing therapies. Limitations of the present study include, small sample size, better education for PDE5i use, which may improve patients response, and concomitant management of risk factors. Other groups of patients with versus without CAD or PDE5i responders versus non-responders are targets of future studies
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.10.M.Sc.2016.Ra.P (Browse shelf(Opens below)) Not for loan 01010110072686000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.10.M.Sc.2016.Ra.P (Browse shelf(Opens below)) 72686.CD Not for loan 01020110072686000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology

The aim of the study is to detect pelvic arterial abnormalities in patients with arteriogenic erectile dysfunction and to correlate the presence of these abnormalities with findings of other investigatory methods, also to conduct a trial of revascularization for selected patients. In all, 30 men with arteriogenic ED Non responders to PDE5 inhibitors therapy and post injection max penile systolic velocity <25 cm/s in reported penile duplex ultrasonography were included. Of these, 25 men under go coronary and pelvic angiography after proper preparation and complete personal, medical, sexual history, laboratory testing, local, general and coronary examination, penile duplex study, also the International Index of Erectile Function Questionnaire were taken. Internal pudendal artery abnormalities are an evident finding in almost all patients with arteriogenig ED. Accordingly, PTA of the internal pudendal artery using drug-eluting stent in patients ateriogenic ED, particularly those non responders to PDE5i therapy, seems to be a safe and feasible option to improve arterial inflow, and can result in regaining erectile function.Further randomized controlled studies are needed to assess the efficacy of this new therapeutic modality as compared to the existing therapies. Limitations of the present study include, small sample size, better education for PDE5i use, which may improve patients response, and concomitant management of risk factors. Other groups of patients with versus without CAD or PDE5i responders versus non-responders are targets of future studies

Issued also as CD

There are no comments on this title.

to post a comment.